{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:36:18Z","timestamp":1790339778033,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ijsu.2015.09.074","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T06:59:21Z","timestamp":1445756361000},"page":"176-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"PA","title":["Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery"],"prefix":"10.1097","volume":"23","author":[{"given":"S.J.","family":"Valle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0150-8338","authenticated-orcid":false,"given":"N.A.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Liauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijsu.2015.09.074_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","article-title":"Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors","volume":"63","author":"Chu","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2015.09.074_bib2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00000658-198606000-00009","article-title":"Malignant ascites. Clinical and experimental observations","volume":"203","author":"Garrison","year":"1986","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ijsu.2015.09.074_bib3","first-page":"376","article-title":"Pathogenesis of ascites tumour growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining","volume":"55","author":"Nagy","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijsu.2015.09.074_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/1097-0142(19890801)64:3<753::AID-CNCR2820640330>3.0.CO;2-Y","article-title":"Malignant ascites of unknown origin","volume":"64","author":"Ringenberg","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2015.09.074_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0885-3924(98)00037-2","article-title":"A\u00a0survey of practice in management of malignant ascites","volume":"16","author":"Lee","year":"1998","journal-title":"J.\u00a0Pain Symptom Manag."},{"key":"10.1016\/j.ijsu.2015.09.074_bib6","doi-asserted-by":"crossref","DOI":"10.3310\/hta12150","article-title":"The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation","volume":"12","author":"Hind","year":"2008","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ijsu.2015.09.074_bib7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/1097-0142(196608)19:8<1096::AID-CNCR2820190808>3.0.CO;2-N","article-title":"Intracavitary administration of radioactive isotopes in the control of effusions due to cancer. Results in 267 patients","volume":"19","author":"Ariel","year":"1966","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2015.09.074_bib8","first-page":"103","article-title":"Palliative treatment of malignant ascites: profile of Catumaxomab","volume":"4","author":"Ammouri","year":"2010","journal-title":"Biologics"},{"key":"10.1016\/j.ijsu.2015.09.074_bib9","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomised trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ijsu.2015.09.074_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-006-9182-x","article-title":"Systematic review on the efficacy of cytoreductive and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"14","author":"Yan","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijsu.2015.09.074_bib11","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1245\/s10434-011-1793-1","article-title":"Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin","volume":"18","author":"Hill","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2015.09.074_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02987754","article-title":"Treatment of malignant peritoneal effusion in digestive and ovarian cancer","volume":"9","author":"Gilly","year":"1992","journal-title":"Med. Oncol. Tumour Pharmacother."},{"key":"10.1016\/j.ijsu.2015.09.074_bib13","first-page":"137","article-title":"Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined modality therapy","volume":"63","author":"Loggie","year":"1997","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ijsu.2015.09.074_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/BF01675656","article-title":"Hyperthermo-chemotherapy combined with cytoreductive surgery for treatment of gastric cancer with peritoneal dissemination","volume":"15","author":"Yonemura","year":"1991","journal-title":"World J. Surg."},{"key":"10.1016\/j.ijsu.2015.09.074_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejso.2007.05.015","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer","volume":"34","author":"Facchiano","year":"2008","journal-title":"EJSO"},{"key":"10.1016\/j.ijsu.2015.09.074_bib16","series-title":"National Cancer Institute Common Toxicity Criteria Version 2","author":"National Cancer Institute","year":"1999"},{"key":"10.1016\/j.ijsu.2015.09.074_bib17","unstructured":"S.J. Valle, N. Alzahrani, W. Liauw, P.H. Sugarbaker, D.L. Morris, Hyperthermic intraperitoneal chemotherapy (HIPEC) methodology, drugs and bidirectional chemotherapy, Indian J. Surg. Oncol. Manuscript ID: IJSO-D-15-00109, (in press)."},{"key":"10.1016\/j.ijsu.2015.09.074_bib18","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1245\/s10434-013-3224-y","article-title":"Efficacy of cytoreductive surgery with hyperthemic intraperitoneal chemotherapy in the management of malignant ascites","volume":"21","author":"Randle","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2015.09.074_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00000658-198606000-00009","article-title":"Malignant ascites. Clinical and experimental observations","volume":"203","author":"Garrison","year":"1986","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.ijsu.2015.09.074_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejso.2006.03.014","article-title":"Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites","volume":"32","author":"Garofalo","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"issue":"13","key":"10.1016\/j.ijsu.2015.09.074_bib21","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1158\/1078-0432.CCR-06-2769","article-title":"Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I\/II study","volume":"13","author":"Burges","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ijsu.2015.09.074_bib22","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1158\/1078-0432.CCR-05-1181","article-title":"Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in ovcar-2 tumor-bearing nude mice","volume":"12","author":"Pourgholami","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijsu.2015.09.074_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1525-1438.2001.11(suppl.1)sup1057.x","article-title":"Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy resistant peritoneal disseminated ovarian cancer","volume":"11","author":"Hager","year":"2001","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ijsu.2015.09.074_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1245\/s10434-007-9571-9","article-title":"Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study","volume":"15","author":"Gesson-Paute","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2015.09.074_bib25","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3748\/wjg.v16.i15.1901","article-title":"Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites","volume":"16","author":"Ba","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijsu.2015.09.074_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1072-7515(01)00980-2","article-title":"Laparoscopic continuous hyperthermic peritoneal perfusion","volume":"193","author":"Chang","year":"2001","journal-title":"J.\u00a0Am. Coll. Surg."},{"key":"10.1016\/j.ijsu.2015.09.074_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLE.0b013e318173a61e","article-title":"Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy","volume":"18","author":"Patriri","year":"2008","journal-title":"Surg. Laparosc. Endosc. Percutan. Tech."},{"issue":"4","key":"10.1016\/j.ijsu.2015.09.074_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jso.21321","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of refractory malignant ascites: a multi-institutional retrospective analysis in 52 patients","volume":"10","author":"Valle","year":"2009","journal-title":"J.\u00a0Surg. Oncol."}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919115012650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919115012650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:01:05Z","timestamp":1677081665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919115012650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":28,"alternative-id":["S1743919115012650"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2015.09.074","relation":{},"ISSN":["1743-9191"],"issn-type":[{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2015.09.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}